RxDoctor Payments Data

Stacey Warren, PA

Physician Assistant · Seattle, WANPI 1346575206

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.6% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Amgen at 36.9% of the total. 2025 is the largest year on record at $851, 2.2 times the $393 reported in 2021. Among physician assistant clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,775in general payments, 2019–2025

Across 187 payments — averaging $14.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • AbbVie$745
  • Johnson & Johnson$441
  • Sanofi$102
  • E.r. Squibb & Sons, L.L.C.$85
  • Organon$82
  • plus $296 from 7 others

What the payments were for

  • Food & beverage$2,57093%
  • Education$2057%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,775 in reported general payments places this provider in the 90th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington →

Medicare billing

Part B allowed, 2024
$73,910
Medicare patients
321
Services billed
1,087

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab14$112,505
Dupixent SyringeDupilumab12$53,123
Dupixent PenDupilumab11$41,848
Tacrolimus16$4,932
Clobetasol Propionate80$3,503
Fluorouracil16$1,209
Doxycycline Monohydrate20$912
Ketoconazole51$779
Triamcinolone Acetonide56$712
Clindamycin Phosphate19$602
Mupirocin53$512
Metronidazole16$461
Imiquimod18$368
Mometasone Furoate17$294
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$222

Paid to pharmacies, not to this prescriber.

Other physician assistant in Seattle

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →